ACM
TECH icon

AlphaStar Capital Management’s Bio-Techne TECH Stock Holding History

AlphaStar Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-72,280
Closed -$8.89M – 409
2021
Q3 		$8.89M Buy
72,280
+21,952
+44% +$2.67M 0.61% 36
2021
Q2 		$5.67M Buy
50,328
+268
+0.5% +$28.2K 0.73% 31
2021
Q1 		$4.78M Buy
+50,060
New +$4.57M 0.74% 30

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

AlphaStar Capital Management's TECH Position: Q4 2021 in Review

AlphaStar Capital Management sold out of Bio-Techne (TECH) in Q4 2021, closing a stake of 72,280 shares — an estimated $8.89M sold.

AlphaStar Capital Management first reported a position in TECH in Q1 2021 and held it in 3 quarters. The position peaked at $8.89M in Q3 2021. 575 funds tracked by Wall St. Rank hold TECH as of Q4 2021.

  • AlphaStar Capital Management reported no remaining Bio-Techne position as of Q4 2021 after selling out during the quarter.
  • AlphaStar Capital Management sold 72,280 Bio-Techne shares in Q4 2021, an estimated $8.89M.
  • AlphaStar Capital Management first reported a position in Bio-Techne in Q1 2021 and held it in 3 quarters.
  • AlphaStar Capital Management's Bio-Techne position peaked at $8.89M in Q3 2021.
  • 575 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2021.

Based on AlphaStar Capital Management's 13F filing for Q4 2021, filed 4 Feb 2022.